NCT05361668 2026-03-19
Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome
Crinetics Pharmaceuticals Inc.
Phase 2 Completed
Clinical Trials
12 trialsNCT07087054 2026-03-10
CAREFNDR
Crinetics Pharmaceuticals Inc.
Phase 3 Recruiting
NCT07450287 2026-03-04
CardioNETPOL
National Institute of Cardiology, Warsaw, Poland
Not yet recruiting
NCT03223428 2024-07-24
RELAX
TerSera Therapeutics LLC
Completed
NCT04713202 2023-02-10
NET-PACS
Big Ten Cancer Research Consortium
Phase 2 Withdrawn
NCT03722511 2022-11-03
Evaluating an Amino Acid Based Medical Food w/ Diarrhea in Carcinoid Syndrome & Other NETs
University of Kentucky
Phase 2 Completed
NCT00774930 2022-10-14
ELECT
Ipsen
Phase 3 Completed
NCT04073017 2021-05-21
Enterade in Carcinoid/Non-Carcinoid Syndrome Neuroendocrine Tumor Patients With Quality of Life Limiting Bowel Frequency
Vanderbilt-Ingram Cancer Center
Phase NA Terminated
NCT01234168 2020-11-05
SYMNET
Ipsen
Completed
NCT04140409 2019-10-25
SCIROCCO
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Phase 4 Terminated
NCT02299089 2017-12-15
Phase II Study of Subcutaneous Inj. Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs)
Camurus AB
Phase 2 Completed
NCT00789841 2010-10-26
Gastrointestinal Motility in Patients With Neuroendocrine Tumors
University of Aarhus
Completed